Stockscreener 앱 받기
3.39
8.13%
-0.30
Terns Pharmaceuticals Inc 주식(TERN)의 최신 뉴스
Terns Pharmaceuticals stock hits 52-week low at $3.54 - Investing.com India
Brokerages Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Target Price at $18.30 - Defense World
William Blair Initiates Coverage on Terns Pharmaceuticals (NASDAQ:TERN) - Defense World
William Blair Initiates Terns Pharmaceuticals at Market Perform -February 28, 2025 at 08:12 am EST - Marketscreener.com
William Blair Initiates Coverage of Terns Pharmaceuticals (TERN) with Market Perform Recommendation - MSN
Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewswire
Terns Pharmaceuticals reports progress in clinical trials By Investing.com - Investing.com Australia
New Terns Pharmaceuticals CFO Receives $2.8M Stock Option Package: What's Behind the Compensation? - StockTitan
Terns Pharmaceuticals reports progress in clinical trials - Investing.com India
Terns Pharmaceuticals Provides Program Updates and - GlobeNewswire
Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th ... - The Bakersfield Californian
Can Terns Pharmaceuticals' $372M Cash Runway Fuel Its Promising CML and Obesity Pipeline? - StockTitan
Terns Pharmaceuticals Names Andrew Gengos as Chief Financial Officer -February 25, 2025 at 04:55 am EST - Marketscreener.com
Its CEO died. The company scrapped a promising program. Now, for their 2nd act. - PharmaVoice
Terns Pharmaceuticals appoints Andrew Gengos as CFO - TipRanks
Terns Pharmaceuticals Appoints Andrew Gengos as CFO - MSN
Terns Pharmaceuticals appoints new CFO to bolster growth By Investing.com - Investing.com Nigeria
Terns Pharmaceuticals appoints new CFO to bolster growth - Investing.com India
Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer - The Manila Times
Can This Former Amgen VP Transform Terns Pharmaceuticals as New CFO? - StockTitan
Terns Pharmaceuticals stock hits 52-week low at $4 - Investing.com India
Terns Pharmaceuticals stock hits 52-week low at $4 By Investing.com - Investing.com Nigeria
Oppenheimer Initiates Coverage of Terns Pharmaceuticals (TERN) with Outperform Recommendation - MSN
Terns Pharmaceuticals Appoints Robert Azelby to Board - TipRanks
Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors - GlobeNewswire
Can This New Board Addition Transform Terns' Oncology Commercialization Strategy? - StockTitan
Savant Capital LLC Makes New $89,000 Investment in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals stock hits 52-week low at $4.16 - MSN
Terns Pharmaceuticals stock hits 52-week low at $4.16 By Investing.com - Investing.com Canada
Bleakley Financial Group LLC Boosts Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals announces CFO transition and consulting agreement - MSN
Terns Pharmaceuticals Inc (TERN) deserves deeper analysis - US Post News
Terns Pharma: I Don't See The Positioning (NASDAQ:TERN) - Seeking Alpha
Terns Pharmaceuticals Inc [TERN] stock for 11,498 USD was acquired by Jung Melita Sun - Knox Daily
Autolus Therapeutics plc ADR [AUTL] Officer makes an insider purchase of 698,741 shares worth 2.96 million. - Knox Daily
LIPO Stock Sees Surge of Approximately 74.16% in Last Five Days - Knox Daily
Quoin Pharmaceuticals Ltd ADR [QNRX] stock for 250,000 USD was acquired by Carter Denise P. - Knox Daily
Sage Therapeutics Inc [SAGE] Records 50-Day SMA of $6.17 - Knox Daily
60 Degrees Pharmaceuticals Inc [SXTP] Records 200-Day SMA of $1.8142 - Knox Daily
PTC Therapeutics Inc [PTCT] Records 200-Day SMA of $38.09 - Knox Daily
EyePoint Pharmaceuticals Inc [EYPT] Shares Fall Approximately -76.18% Over the Year - Knox Daily
Travere Therapeutics Inc [TVTX] Records 50-Day SMA of $18.85 - Knox Daily
Lexicon Pharmaceuticals Inc [LXRX] Records 50-Day SMA of $0.7840 - Knox Daily
C4 Therapeutics Inc [CCCC] Records 200-Day SMA of $5.28 - Knox Daily
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Acquired by E. Ohman J or Asset Management AB - Armenian Reporter
3.13%
1.23%
자본화:
|
볼륨(24시간):